Introduction: Diabetes mellitus (DM) is a prevalent non communicable disease. Aims & objectives: Aim of the present study is to evaluate the
efcacy of Omega-3 Fatty acids and Fenobrate in the treatment of dyslipidemia in the patients of Type-II Diabetes Mellitus with an objective to
provide guidelines for better treatment of dyslipidemia in patients with Type-II Diabetes Mellitus. Material and method: Estimation of HbAlc
was be done before starting therapy and thereafter every 12 weeks upto 24 weeks. the Department of Pharmacology, Darbhanga Medical College,
Laheriasaria, with all facilities such as was furnished laboratory, necessary equipments and infrastructure. Conclusion: Fenobrate effectively
controlled the total cholesterol and TG levels, increased the HDLcholesterol level, especially in its small fraction, and improved vascular function
of patients with type 2 diabe
Prevalence and Determinants of Peripheral Neuropathy Among Adult Type II Diabetes Mellitus Patients Attending a Non-communicable Disease Clinic in Rural South India
